Groowe Groowe / Newsroom / PFE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PFE News

Pfizer Inc.

TailorMed Introduces Next Phase of Growth with Expanded Medication Success Platform at AXS26

accessnewswire.com
PFE

Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors

prnewswire.com
ARMP PFE

Respiratory Syncytial Virus Vaccines Market Projected to Surpass $113 Billion by 2035 – SNS Insider

globenewswire.com
GSK PFE AZN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

accessnewswire.com
VALN PFE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

accessnewswire.com
VALN PFE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

accessnewswire.com
VALN PFE

Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics

globenewswire.com
AKBA GSK VRTX PFE SNY NVS JNJ

Bristol Myers Squibb and Pfizer to Make Eliquis ® (apixaban) Available via Mark Cuban Cost Plus Drug Company

businesswire.com
BMY PFE

Oncology Clinical Trials Research Report 2026: $20+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
PFE JNJ MRK ABBV NVS CHRS

Infectious Disease Clinical Trials Research Report 2026: $21.25 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
PFE MRNA